2010
DOI: 10.3109/14756366.2010.496364
|View full text |Cite
|
Sign up to set email alerts
|

Prediction of HIV-1 protease inhibitory activity of 4-hydroxy-5,6-dihydropyran-2-ones: QSAR study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2011
2011
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(3 citation statements)
references
References 16 publications
0
3
0
Order By: Relevance
“…Dutchowicz et al 8 reported a QSAR study of some benzoxazinone derivatives but the maximum correlation coefficient of the model is 0.799. The 2D QSAR studies have been carried out for anti-HIV activities of different groups of compounds [9][10][11][12][13][14][15][16][17][18][19][20][21][22][23] . Comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) have also been carried out for anti-HIV activity of a given set of molecules in rational drug design and its related applications [24][25][26][27][28][29][30][31][32][33][34][35][36][37] .…”
Section: Research Articlementioning
confidence: 99%
“…Dutchowicz et al 8 reported a QSAR study of some benzoxazinone derivatives but the maximum correlation coefficient of the model is 0.799. The 2D QSAR studies have been carried out for anti-HIV activities of different groups of compounds [9][10][11][12][13][14][15][16][17][18][19][20][21][22][23] . Comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) have also been carried out for anti-HIV activity of a given set of molecules in rational drug design and its related applications [24][25][26][27][28][29][30][31][32][33][34][35][36][37] .…”
Section: Research Articlementioning
confidence: 99%
“…In this context, there is a great demand for predictive models to design new drugs with improved properties and diminished side effects [1]. Furthermore, there is also a demand for new methods that replace and reduce the use of laboratory animals [2]. These methods should be used in the design and evaluation of experimental tests and in the selection of appropriate test compounds for validation studies [3].…”
Section: Introductionmentioning
confidence: 99%
“…Considering a myriad of drugs' side effects, viruses' high tendency to mutate and develop drug resistance, and the fact that the last time a HIV protease inhibitor was approved by US FDA in 2006 [22], the design of new protease inhibitors in subnanomolar regime and ideally without side reactions is of paramount importance. In recent years, numerous quantitative structure-activity relationship (QSAR) studies have appeared, trying to connect the structural characteristics of the inhibitor -HIV-1 protease complexes with the inhibition constant and ADMET properties [14,[23][24][25][26][27][28][29]. Amin et al have statistically validated different modeling approaches (Bayesian classification, HQSAR, 3D-QSAR CoMFA and CoMSIA analyses).…”
mentioning
confidence: 99%